All bills
SB 1264 Referred

SB 1264 - Currently, the prohibition on the prescription or administration of cross-sex hormones or puberty-blocking drugs for the purpose of a gender transition for persons under 18 years of age expires on August 28, 2027. This act removes that expiration date. This act is identical to a provision in SB 249 (2025), HCS#2/SS#2/SCS/SB 10 (2025), SB 26 (2025), SB 493 (2025), SB 1185 (2024), SB 726 (2024), and SB 776 (2024), substantially similar to SB 75 (2025), and similar to provisions in HCS/HBs 1520, 1519, 2355, and 2357 (2024). SARAH HASKINS

Official Bill Page

Loading official bill page…

Legislative Timeline

3 actions
  1. Jan 27, 2026 upper
    Second Read and Referred S Families, Seniors and Health Committee
  2. Jan 7, 2026 upper
    S First Read
  3. Dec 1, 2025 upper
    Prefiled
About this civic dataset

About this legislation view

Track federal and state bills and legislation — browse by chamber, status, and day, with summaries and sponsor details, updated daily on Civic Stream.

Use the scope, chamber, status, and search controls to move from the national legislation picture down to an exact state or legislative stage.